| 辅加更昔洛韦治疗进展性卒中的临床分析 |
| |
| 引用本文： | 付庆贤,荣根满. 辅加更昔洛韦治疗进展性卒中的临床分析[J]. 中国当代医药, 2011, 0(33): 53-54 |
| |
| 作者姓名： | 付庆贤 荣根满 |
| |
| 作者单位： | 辽宁省朝阳市喀左县中蒙医院神经内科;中铁十九局集团中心医院 |
| |
| 摘 要： | 目的：探讨辅加更昔洛韦治疗进展性卒中的临床疗效。方法：将发病在72h内的急性进展性脑梗死患者64例分为治疗组和对照组,各32例。治疗组在对照组常规治疗的基础上加用更昔洛韦治疗。观察两组用药后临床症状与体征停止进展的天数,并于治疗前及治疗后3、7、14、21d分别进行神经功能缺损程度评分。结果：治疗组较对照组进展期明显缩短,神经功能缺损程度明显改善,治愈率和总有效率明显增加（P〈0.01）。结论：辅加更昔洛韦抗病毒药治疗进展性卒中疗效显著,早期加用效果较好,疗程以2～3周为宜。
|
| 关 键 词： | 抗病毒药 更昔洛韦 进展性卒中 疗效 |
The clinical curative effect of the ganciclovir in treatment evolutional apoplexy |
| |
| FU Qingxian,RONG Genman. The clinical curative effect of the ganciclovir in treatment evolutional apoplexy[J]. http://www.botanicus.org/, 2011, 0(33): 53-54 |
| |
| Authors: | FU Qingxian RONG Genman |
| |
| Affiliation: | 1.Nerve Internal Medicine Department of Zhongmeng Hospital of Kazuo County, Chaoyang City, Liaoning Province, Kazuo 122000, China; 2.The Central Hospital of Zhong Tie 19 Office, Liaoning Province, Liaoyang 111000, China |
| |
| Abstract: | Objective： To investigate the clinical efficacy of stroke in progression in the treatment of ganciclovir. Methods： 64 cases of acute progressive cerebral infarction happened in seventy-two hours were divided into treatment group （32 cases） and control group （32 cases）. Control group were given conventional therapy, but treatment group were given ganciclovir in addition to conventional therapy. Control of disease condition and NIHSS of two group were observed. Results： Control of disease condition, NIHSS, cure rate and total effective rate of treatment group were better than control group （ P0.01）. Conclusion： Ganciclovir is particularly effective against stroke in progression. If ganciclovir is used early, its clinical efficacy is better. Two to three weeks is optimal period of treatment. |
| |
| Keywords: | Antivirotic Ganciclovir Stroke in progression Clinical efficacy |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
